|
by Banerjee, Srabani, Argáez, Charlene
Published 2017
“... settings. Additionally, this report aims to review the evidence-based guidelines regarding...”Published 2017
Canadian Agency for Drugs and Technologies in Health
|
by Banerjee, Srabani, Ford, Caitlyn
Published 2018
“..., this report aims to review the evidence-based guidelines regarding the diagnosis of suspected GA strep...”Published 2018
Canadian Agency for Drugs and Technologies in Health
|
by Banerjee, Srabani, Ford, Caitlyn
Published 2018
“..., this report aims to review the evidence-based guidelines regarding the diagnosis of suspected GA strep...”Published 2018
Canadian Agency for Drugs and Technologies in Health
|
by Banerjee, Srabani, Argáez, Charlene
Published 2019
“..., this report aims to review the evidence-based guidelines regarding multidisciplinary treatment programs...”Published 2019
Canadian Agency for Drugs and Technologies in Health
|
by Banerjee, Srabani, Argáez, Charlene
Published 2017
“... settings. Additionally, this report aims to review the evidence-based guidelines regarding...”Published 2017
Canadian Agency for Drugs and Technologies in Health
|
by Banerjee, Srabani, Argáez, Charlene
Published 2019
“..., this report aims to review the evidence-based guidelines regarding multidisciplinary treatment programs...”Published 2019
Canadian Agency for Drugs and Technologies in Health
|
by Banerjee, Srabani, Spry, Carolyn
Published 2017
“..., usual care or active treatment for the second disorder. Additionally, this review aims to review...”Published 2017
Canadian Agency for Drugs and Technologies in Health
|
by Banerjee, Srabani, Picheca, Lory
Published 2017
“... treatment in patients with atrial fibrillation (AF). Additionally, this report aims to review evidence-based...”Published 2017
Canadian Agency for Drugs and Technologies in Health
|
by Banerjee, Srabani, Picheca, Lory
Published 2017
“... treatment in patients with atrial fibrillation (AF). Additionally, this report aims to review evidence-based...”Published 2017
Canadian Agency for Drugs and Technologies in Health
|
by Banerjee, Srabani, Featherstone, Robin
Published 2019
“... aims to review the evidence-based guidelines regarding the use of povidone-iodine for biofilm...”Published 2019
Canadian Agency for Drugs and Technologies in Health
- 1
- 2